TW300166B - - Google Patents
Download PDFInfo
- Publication number
- TW300166B TW300166B TW082102065A TW82102065A TW300166B TW 300166 B TW300166 B TW 300166B TW 082102065 A TW082102065 A TW 082102065A TW 82102065 A TW82102065 A TW 82102065A TW 300166 B TW300166 B TW 300166B
- Authority
- TW
- Taiwan
- Prior art keywords
- compound
- acid
- composition
- item
- weight
- Prior art date
Links
- 239000000203 mixture Substances 0.000 claims abstract description 41
- 150000001875 compounds Chemical class 0.000 claims abstract description 32
- 239000002537 cosmetic Substances 0.000 claims abstract description 19
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 claims abstract description 8
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 claims abstract description 4
- 239000002253 acid Substances 0.000 claims description 17
- 239000004480 active ingredient Substances 0.000 claims description 10
- 239000000126 substance Substances 0.000 claims description 7
- 239000002245 particle Substances 0.000 claims description 4
- 239000004793 Polystyrene Substances 0.000 claims 1
- 241000277331 Salmonidae Species 0.000 claims 1
- 150000002504 iridium compounds Chemical class 0.000 claims 1
- 229920002223 polystyrene Polymers 0.000 claims 1
- 239000003795 chemical substances by application Substances 0.000 abstract description 17
- 238000000034 method Methods 0.000 abstract description 11
- 230000001105 regulatory effect Effects 0.000 abstract description 3
- -1 1H-quinazol-1-yl-methyl Chemical group 0.000 description 23
- 239000000047 product Substances 0.000 description 19
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 19
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 17
- HEMHJVSKTPXQMS-UHFFFAOYSA-M sodium hydroxide Inorganic materials [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 14
- DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 description 12
- 239000000243 solution Substances 0.000 description 12
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 11
- 238000002360 preparation method Methods 0.000 description 11
- 210000003491 skin Anatomy 0.000 description 10
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 9
- 239000004615 ingredient Substances 0.000 description 9
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 description 9
- 239000003921 oil Substances 0.000 description 8
- 239000003755 preservative agent Substances 0.000 description 8
- 238000003756 stirring Methods 0.000 description 8
- 238000009472 formulation Methods 0.000 description 7
- 239000003205 fragrance Substances 0.000 description 7
- 239000007788 liquid Substances 0.000 description 7
- 239000006210 lotion Substances 0.000 description 7
- 239000011541 reaction mixture Substances 0.000 description 7
- GVJHHUAWPYXKBD-UHFFFAOYSA-N (±)-α-Tocopherol Chemical compound OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 description 6
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 6
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 6
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 6
- 235000011187 glycerol Nutrition 0.000 description 6
- VNWKTOKETHGBQD-UHFFFAOYSA-N methane Chemical compound C VNWKTOKETHGBQD-UHFFFAOYSA-N 0.000 description 6
- 239000002562 thickening agent Substances 0.000 description 6
- 238000006243 chemical reaction Methods 0.000 description 5
- 239000003814 drug Substances 0.000 description 5
- 125000004494 ethyl ester group Chemical group 0.000 description 5
- 239000002502 liposome Substances 0.000 description 5
- 150000003839 salts Chemical class 0.000 description 5
- 239000002904 solvent Substances 0.000 description 5
- 239000004094 surface-active agent Substances 0.000 description 5
- 125000004215 2,4-difluorophenyl group Chemical group [H]C1=C([H])C(*)=C(F)C([H])=C1F 0.000 description 4
- 241000208680 Hamamelis mollis Species 0.000 description 4
- LRHPLDYGYMQRHN-UHFFFAOYSA-N N-Butanol Chemical compound CCCCO LRHPLDYGYMQRHN-UHFFFAOYSA-N 0.000 description 4
- AMQJEAYHLZJPGS-UHFFFAOYSA-N N-Pentanol Chemical compound CCCCCO AMQJEAYHLZJPGS-UHFFFAOYSA-N 0.000 description 4
- NBIIXXVUZAFLBC-UHFFFAOYSA-N Phosphoric acid Chemical compound OP(O)(O)=O NBIIXXVUZAFLBC-UHFFFAOYSA-N 0.000 description 4
- NQRYJNQNLNOLGT-UHFFFAOYSA-N Piperidine Chemical compound C1CCNCC1 NQRYJNQNLNOLGT-UHFFFAOYSA-N 0.000 description 4
- 150000001298 alcohols Chemical class 0.000 description 4
- 239000000872 buffer Substances 0.000 description 4
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 4
- XBDQKXXYIPTUBI-UHFFFAOYSA-N dimethylselenoniopropionate Natural products CCC(O)=O XBDQKXXYIPTUBI-UHFFFAOYSA-N 0.000 description 4
- 150000002191 fatty alcohols Chemical class 0.000 description 4
- 239000007789 gas Substances 0.000 description 4
- 239000004816 latex Substances 0.000 description 4
- 229920000126 latex Polymers 0.000 description 4
- 150000002632 lipids Chemical class 0.000 description 4
- 125000000956 methoxy group Chemical group [H]C([H])([H])O* 0.000 description 4
- 235000013336 milk Nutrition 0.000 description 4
- 239000008267 milk Substances 0.000 description 4
- 210000004080 milk Anatomy 0.000 description 4
- 210000002374 sebum Anatomy 0.000 description 4
- 230000028327 secretion Effects 0.000 description 4
- 239000011782 vitamin Substances 0.000 description 4
- 229930003231 vitamin Natural products 0.000 description 4
- 229940088594 vitamin Drugs 0.000 description 4
- 235000013343 vitamin Nutrition 0.000 description 4
- 239000000080 wetting agent Substances 0.000 description 4
- 229940118846 witch hazel Drugs 0.000 description 4
- 125000004201 2,4-dichlorophenyl group Chemical group [H]C1=C([H])C(*)=C(Cl)C([H])=C1Cl 0.000 description 3
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 3
- 208000001840 Dandruff Diseases 0.000 description 3
- YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 description 3
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 3
- MUBZPKHOEPUJKR-UHFFFAOYSA-N Oxalic acid Chemical compound OC(=O)C(O)=O MUBZPKHOEPUJKR-UHFFFAOYSA-N 0.000 description 3
- KWYUFKZDYYNOTN-UHFFFAOYSA-M Potassium hydroxide Chemical compound [OH-].[K+] KWYUFKZDYYNOTN-UHFFFAOYSA-M 0.000 description 3
- YGSDEFSMJLZEOE-UHFFFAOYSA-N Salicylic acid Natural products OC(=O)C1=CC=CC=C1O YGSDEFSMJLZEOE-UHFFFAOYSA-N 0.000 description 3
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 3
- YXFVVABEGXRONW-UHFFFAOYSA-N Toluene Chemical compound CC1=CC=CC=C1 YXFVVABEGXRONW-UHFFFAOYSA-N 0.000 description 3
- 239000003963 antioxidant agent Substances 0.000 description 3
- 235000006708 antioxidants Nutrition 0.000 description 3
- 239000007864 aqueous solution Substances 0.000 description 3
- 230000002079 cooperative effect Effects 0.000 description 3
- 238000000354 decomposition reaction Methods 0.000 description 3
- 238000004043 dyeing Methods 0.000 description 3
- 239000000839 emulsion Substances 0.000 description 3
- 238000002309 gasification Methods 0.000 description 3
- 239000001866 hydroxypropyl methyl cellulose Substances 0.000 description 3
- 235000010979 hydroxypropyl methyl cellulose Nutrition 0.000 description 3
- 229920003088 hydroxypropyl methyl cellulose Polymers 0.000 description 3
- 239000005457 ice water Substances 0.000 description 3
- 239000010410 layer Substances 0.000 description 3
- 125000000250 methylamino group Chemical group [H]N(*)C([H])([H])[H] 0.000 description 3
- VLKZOEOYAKHREP-UHFFFAOYSA-N n-Hexane Chemical compound CCCCCC VLKZOEOYAKHREP-UHFFFAOYSA-N 0.000 description 3
- 239000012044 organic layer Substances 0.000 description 3
- 239000002304 perfume Substances 0.000 description 3
- 150000003904 phospholipids Chemical class 0.000 description 3
- 230000002829 reductive effect Effects 0.000 description 3
- 239000002453 shampoo Substances 0.000 description 3
- 239000011734 sodium Substances 0.000 description 3
- 239000007787 solid Substances 0.000 description 3
- MTCFGRXMJLQNBG-REOHCLBHSA-N (2S)-2-Amino-3-hydroxypropansäure Chemical compound OC[C@H](N)C(O)=O MTCFGRXMJLQNBG-REOHCLBHSA-N 0.000 description 2
- HZAXFHJVJLSVMW-UHFFFAOYSA-N 2-Aminoethan-1-ol Chemical compound NCCO HZAXFHJVJLSVMW-UHFFFAOYSA-N 0.000 description 2
- 241000208340 Araliaceae Species 0.000 description 2
- 241000208983 Arnica Species 0.000 description 2
- 241000416162 Astragalus gummifer Species 0.000 description 2
- 235000018185 Betula X alpestris Nutrition 0.000 description 2
- 235000018212 Betula X uliginosa Nutrition 0.000 description 2
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 2
- AEMRFAOFKBGASW-UHFFFAOYSA-N Glycolic acid Chemical compound OCC(O)=O AEMRFAOFKBGASW-UHFFFAOYSA-N 0.000 description 2
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 description 2
- OFOBLEOULBTSOW-UHFFFAOYSA-N Malonic acid Chemical compound OC(=O)CC(O)=O OFOBLEOULBTSOW-UHFFFAOYSA-N 0.000 description 2
- PXHVJJICTQNCMI-UHFFFAOYSA-N Nickel Chemical compound [Ni] PXHVJJICTQNCMI-UHFFFAOYSA-N 0.000 description 2
- 235000005035 Panax pseudoginseng ssp. pseudoginseng Nutrition 0.000 description 2
- 235000003140 Panax quinquefolius Nutrition 0.000 description 2
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 description 2
- 244000178231 Rosmarinus officinalis Species 0.000 description 2
- MTCFGRXMJLQNBG-UHFFFAOYSA-N Serine Natural products OCC(N)C(O)=O MTCFGRXMJLQNBG-UHFFFAOYSA-N 0.000 description 2
- QAOWNCQODCNURD-UHFFFAOYSA-N Sulfuric acid Chemical compound OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 description 2
- FEWJPZIEWOKRBE-UHFFFAOYSA-N Tartaric Acid Chemical compound [H+].[H+].[O-]C(=O)C(O)C(O)C([O-])=O FEWJPZIEWOKRBE-UHFFFAOYSA-N 0.000 description 2
- GWEVSGVZZGPLCZ-UHFFFAOYSA-N Titan oxide Chemical compound O=[Ti]=O GWEVSGVZZGPLCZ-UHFFFAOYSA-N 0.000 description 2
- 229920001615 Tragacanth Polymers 0.000 description 2
- 229930003427 Vitamin E Natural products 0.000 description 2
- 206010000496 acne Diseases 0.000 description 2
- 239000003513 alkali Substances 0.000 description 2
- 229910000147 aluminium phosphate Inorganic materials 0.000 description 2
- 229940124599 anti-inflammatory drug Drugs 0.000 description 2
- 230000003078 antioxidant effect Effects 0.000 description 2
- 239000002585 base Substances 0.000 description 2
- 230000008901 benefit Effects 0.000 description 2
- 235000012000 cholesterol Nutrition 0.000 description 2
- 238000005336 cracking Methods 0.000 description 2
- 239000013078 crystal Substances 0.000 description 2
- 238000004090 dissolution Methods 0.000 description 2
- 239000000975 dye Substances 0.000 description 2
- 230000000694 effects Effects 0.000 description 2
- 239000003792 electrolyte Substances 0.000 description 2
- 150000002148 esters Chemical class 0.000 description 2
- 238000002474 experimental method Methods 0.000 description 2
- 230000001815 facial effect Effects 0.000 description 2
- 210000001061 forehead Anatomy 0.000 description 2
- 239000012458 free base Substances 0.000 description 2
- WIGCFUFOHFEKBI-UHFFFAOYSA-N gamma-tocopherol Natural products CC(C)CCCC(C)CCCC(C)CCCC1CCC2C(C)C(O)C(C)C(C)C2O1 WIGCFUFOHFEKBI-UHFFFAOYSA-N 0.000 description 2
- 239000000499 gel Substances 0.000 description 2
- 235000008434 ginseng Nutrition 0.000 description 2
- 238000000227 grinding Methods 0.000 description 2
- 150000008282 halocarbons Chemical class 0.000 description 2
- BXWNKGSJHAJOGX-UHFFFAOYSA-N hexadecan-1-ol Chemical compound CCCCCCCCCCCCCCCCO BXWNKGSJHAJOGX-UHFFFAOYSA-N 0.000 description 2
- 239000000413 hydrolysate Substances 0.000 description 2
- 230000007062 hydrolysis Effects 0.000 description 2
- 238000006460 hydrolysis reaction Methods 0.000 description 2
- UFVKGYZPFZQRLF-UHFFFAOYSA-N hydroxypropyl methyl cellulose Chemical compound OC1C(O)C(OC)OC(CO)C1OC1C(O)C(O)C(OC2C(C(O)C(OC3C(C(O)C(O)C(CO)O3)O)C(CO)O2)O)C(CO)O1 UFVKGYZPFZQRLF-UHFFFAOYSA-N 0.000 description 2
- 238000009434 installation Methods 0.000 description 2
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 description 2
- BJEPYKJPYRNKOW-UHFFFAOYSA-N malic acid Chemical compound OC(=O)C(O)CC(O)=O BJEPYKJPYRNKOW-UHFFFAOYSA-N 0.000 description 2
- 239000000463 material Substances 0.000 description 2
- 238000002844 melting Methods 0.000 description 2
- 230000008018 melting Effects 0.000 description 2
- GLDOVTGHNKAZLK-UHFFFAOYSA-N octadecan-1-ol Chemical compound CCCCCCCCCCCCCCCCCCO GLDOVTGHNKAZLK-UHFFFAOYSA-N 0.000 description 2
- 239000003960 organic solvent Substances 0.000 description 2
- FJKROLUGYXJWQN-UHFFFAOYSA-N papa-hydroxy-benzoic acid Natural products OC(=O)C1=CC=C(O)C=C1 FJKROLUGYXJWQN-UHFFFAOYSA-N 0.000 description 2
- 239000000049 pigment Substances 0.000 description 2
- 239000000419 plant extract Substances 0.000 description 2
- 239000004033 plastic Substances 0.000 description 2
- 229920003023 plastic Polymers 0.000 description 2
- 239000011591 potassium Substances 0.000 description 2
- 229910052700 potassium Inorganic materials 0.000 description 2
- BWHMMNNQKKPAPP-UHFFFAOYSA-L potassium carbonate Chemical compound [K+].[K+].[O-]C([O-])=O BWHMMNNQKKPAPP-UHFFFAOYSA-L 0.000 description 2
- 239000000843 powder Substances 0.000 description 2
- 239000002244 precipitate Substances 0.000 description 2
- BDERNNFJNOPAEC-UHFFFAOYSA-N propan-1-ol Chemical compound CCCO BDERNNFJNOPAEC-UHFFFAOYSA-N 0.000 description 2
- 235000019260 propionic acid Nutrition 0.000 description 2
- IUVKMZGDUIUOCP-BTNSXGMBSA-N quinbolone Chemical compound O([C@H]1CC[C@H]2[C@H]3[C@@H]([C@]4(C=CC(=O)C=C4CC3)C)CC[C@@]21C)C1=CCCC1 IUVKMZGDUIUOCP-BTNSXGMBSA-N 0.000 description 2
- 229960004889 salicylic acid Drugs 0.000 description 2
- QZAYGJVTTNCVMB-UHFFFAOYSA-N serotonin Chemical compound C1=C(O)C=C2C(CCN)=CNC2=C1 QZAYGJVTTNCVMB-UHFFFAOYSA-N 0.000 description 2
- 239000002884 skin cream Substances 0.000 description 2
- 229910052708 sodium Inorganic materials 0.000 description 2
- 229930003799 tocopherol Natural products 0.000 description 2
- 229960001295 tocopherol Drugs 0.000 description 2
- 235000010384 tocopherol Nutrition 0.000 description 2
- 239000011732 tocopherol Substances 0.000 description 2
- 239000000196 tragacanth Substances 0.000 description 2
- 235000010487 tragacanth Nutrition 0.000 description 2
- 229940116362 tragacanth Drugs 0.000 description 2
- 238000011282 treatment Methods 0.000 description 2
- 235000019165 vitamin E Nutrition 0.000 description 2
- 239000011709 vitamin E Substances 0.000 description 2
- 229940046009 vitamin E Drugs 0.000 description 2
- GVJHHUAWPYXKBD-IEOSBIPESA-N α-tocopherol Chemical compound OC1=C(C)C(C)=C2O[C@@](CCC[C@H](C)CCC[C@H](C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-IEOSBIPESA-N 0.000 description 2
- PUPZLCDOIYMWBV-UHFFFAOYSA-N (+/-)-1,3-Butanediol Chemical compound CC(O)CCO PUPZLCDOIYMWBV-UHFFFAOYSA-N 0.000 description 1
- PORPENFLTBBHSG-MGBGTMOVSA-N 1,2-dihexadecanoyl-sn-glycerol-3-phosphate Chemical compound CCCCCCCCCCCCCCCC(=O)OC[C@H](COP(O)(O)=O)OC(=O)CCCCCCCCCCCCCCC PORPENFLTBBHSG-MGBGTMOVSA-N 0.000 description 1
- RYCNUMLMNKHWPZ-SNVBAGLBSA-N 1-acetyl-sn-glycero-3-phosphocholine Chemical compound CC(=O)OC[C@@H](O)COP([O-])(=O)OCC[N+](C)(C)C RYCNUMLMNKHWPZ-SNVBAGLBSA-N 0.000 description 1
- LODHFNUFVRVKTH-ZHACJKMWSA-N 2-hydroxy-n'-[(e)-3-phenylprop-2-enoyl]benzohydrazide Chemical compound OC1=CC=CC=C1C(=O)NNC(=O)\C=C\C1=CC=CC=C1 LODHFNUFVRVKTH-ZHACJKMWSA-N 0.000 description 1
- BMYNFMYTOJXKLE-UHFFFAOYSA-N 3-azaniumyl-2-hydroxypropanoate Chemical compound NCC(O)C(O)=O BMYNFMYTOJXKLE-UHFFFAOYSA-N 0.000 description 1
- WUBBRNOQWQTFEX-UHFFFAOYSA-N 4-aminosalicylic acid Chemical compound NC1=CC=C(C(O)=O)C(O)=C1 WUBBRNOQWQTFEX-UHFFFAOYSA-N 0.000 description 1
- HIQIXEFWDLTDED-UHFFFAOYSA-N 4-hydroxy-1-piperidin-4-ylpyrrolidin-2-one Chemical compound O=C1CC(O)CN1C1CCNCC1 HIQIXEFWDLTDED-UHFFFAOYSA-N 0.000 description 1
- 208000002874 Acne Vulgaris Diseases 0.000 description 1
- NIXOWILDQLNWCW-UHFFFAOYSA-N Acrylic acid Chemical group OC(=O)C=C NIXOWILDQLNWCW-UHFFFAOYSA-N 0.000 description 1
- 241001116389 Aloe Species 0.000 description 1
- 239000005995 Aluminium silicate Substances 0.000 description 1
- 101100515517 Arabidopsis thaliana XI-I gene Proteins 0.000 description 1
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 1
- 241000894006 Bacteria Species 0.000 description 1
- 241001474374 Blennius Species 0.000 description 1
- UXVMQQNJUSDDNG-UHFFFAOYSA-L Calcium chloride Chemical group [Cl-].[Cl-].[Ca+2] UXVMQQNJUSDDNG-UHFFFAOYSA-L 0.000 description 1
- ZAMOUSCENKQFHK-UHFFFAOYSA-N Chlorine atom Chemical compound [Cl] ZAMOUSCENKQFHK-UHFFFAOYSA-N 0.000 description 1
- KRKNYBCHXYNGOX-UHFFFAOYSA-K Citrate Chemical compound [O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O KRKNYBCHXYNGOX-UHFFFAOYSA-K 0.000 description 1
- 241001137251 Corvidae Species 0.000 description 1
- 235000009917 Crataegus X brevipes Nutrition 0.000 description 1
- 235000013204 Crataegus X haemacarpa Nutrition 0.000 description 1
- 235000009685 Crataegus X maligna Nutrition 0.000 description 1
- 235000009444 Crataegus X rubrocarnea Nutrition 0.000 description 1
- 235000009486 Crataegus bullatus Nutrition 0.000 description 1
- 235000017181 Crataegus chrysocarpa Nutrition 0.000 description 1
- 235000009682 Crataegus limnophila Nutrition 0.000 description 1
- 240000000171 Crataegus monogyna Species 0.000 description 1
- 235000004423 Crataegus monogyna Nutrition 0.000 description 1
- 235000002313 Crataegus paludosa Nutrition 0.000 description 1
- 235000009840 Crataegus x incaedua Nutrition 0.000 description 1
- 206010011732 Cyst Diseases 0.000 description 1
- ZAKOWWREFLAJOT-CEFNRUSXSA-N D-alpha-tocopherylacetate Chemical compound CC(=O)OC1=C(C)C(C)=C2O[C@@](CCC[C@H](C)CCC[C@H](C)CCCC(C)C)(C)CCC2=C1C ZAKOWWREFLAJOT-CEFNRUSXSA-N 0.000 description 1
- SNPLKNRPJHDVJA-ZETCQYMHSA-N D-panthenol Chemical compound OCC(C)(C)[C@@H](O)C(=O)NCCCO SNPLKNRPJHDVJA-ZETCQYMHSA-N 0.000 description 1
- YXHKONLOYHBTNS-UHFFFAOYSA-N Diazomethane Chemical compound C=[N+]=[N-] YXHKONLOYHBTNS-UHFFFAOYSA-N 0.000 description 1
- 206010013911 Dysgeusia Diseases 0.000 description 1
- KCXVZYZYPLLWCC-UHFFFAOYSA-N EDTA Chemical compound OC(=O)CN(CC(O)=O)CCN(CC(O)=O)CC(O)=O KCXVZYZYPLLWCC-UHFFFAOYSA-N 0.000 description 1
- 241000975394 Evechinus chloroticus Species 0.000 description 1
- 208000010201 Exanthema Diseases 0.000 description 1
- VZCYOOQTPOCHFL-OWOJBTEDSA-N Fumaric acid Chemical compound OC(=O)\C=C\C(O)=O VZCYOOQTPOCHFL-OWOJBTEDSA-N 0.000 description 1
- 241001071795 Gentiana Species 0.000 description 1
- DCXXMTOCNZCJGO-UHFFFAOYSA-N Glycerol trioctadecanoate Natural products CCCCCCCCCCCCCCCCCC(=O)OCC(OC(=O)CCCCCCCCCCCCCCCCC)COC(=O)CCCCCCCCCCCCCCCCC DCXXMTOCNZCJGO-UHFFFAOYSA-N 0.000 description 1
- SQUHHTBVTRBESD-UHFFFAOYSA-N Hexa-Ac-myo-Inositol Natural products CC(=O)OC1C(OC(C)=O)C(OC(C)=O)C(OC(C)=O)C(OC(C)=O)C1OC(C)=O SQUHHTBVTRBESD-UHFFFAOYSA-N 0.000 description 1
- 229920002153 Hydroxypropyl cellulose Polymers 0.000 description 1
- 206010020649 Hyperkeratosis Diseases 0.000 description 1
- 239000005909 Kieselgur Substances 0.000 description 1
- JVTAAEKCZFNVCJ-UHFFFAOYSA-M Lactate Chemical compound CC(O)C([O-])=O JVTAAEKCZFNVCJ-UHFFFAOYSA-M 0.000 description 1
- GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 description 1
- 239000004166 Lanolin Substances 0.000 description 1
- AFVFQIVMOAPDHO-UHFFFAOYSA-N Methanesulfonic acid Chemical compound CS(O)(=O)=O AFVFQIVMOAPDHO-UHFFFAOYSA-N 0.000 description 1
- 241001416180 Moschidae Species 0.000 description 1
- GRYLNZFGIOXLOG-UHFFFAOYSA-N Nitric acid Chemical compound O[N+]([O-])=O GRYLNZFGIOXLOG-UHFFFAOYSA-N 0.000 description 1
- REYJJPSVUYRZGE-UHFFFAOYSA-N Octadecylamine Chemical compound CCCCCCCCCCCCCCCCCCN REYJJPSVUYRZGE-UHFFFAOYSA-N 0.000 description 1
- 229910019142 PO4 Inorganic materials 0.000 description 1
- 239000004264 Petrolatum Substances 0.000 description 1
- 239000002202 Polyethylene glycol Substances 0.000 description 1
- 229920001214 Polysorbate 60 Polymers 0.000 description 1
- XBDQKXXYIPTUBI-UHFFFAOYSA-M Propionate Chemical compound CCC([O-])=O XBDQKXXYIPTUBI-UHFFFAOYSA-M 0.000 description 1
- QOSMNYMQXIVWKY-UHFFFAOYSA-N Propyl levulinate Chemical compound CCCOC(=O)CCC(C)=O QOSMNYMQXIVWKY-UHFFFAOYSA-N 0.000 description 1
- 240000004808 Saccharomyces cerevisiae Species 0.000 description 1
- 241000209051 Saccharum Species 0.000 description 1
- 241000270295 Serpentes Species 0.000 description 1
- 229920002125 Sokalan® Polymers 0.000 description 1
- HVUMOYIDDBPOLL-XWVZOOPGSA-N Sorbitan monostearate Chemical compound CCCCCCCCCCCCCCCCCC(=O)OC[C@@H](O)[C@H]1OC[C@H](O)[C@H]1O HVUMOYIDDBPOLL-XWVZOOPGSA-N 0.000 description 1
- KDYFGRWQOYBRFD-UHFFFAOYSA-N Succinic acid Natural products OC(=O)CCC(O)=O KDYFGRWQOYBRFD-UHFFFAOYSA-N 0.000 description 1
- NINIDFKCEFEMDL-UHFFFAOYSA-N Sulfur Chemical compound [S] NINIDFKCEFEMDL-UHFFFAOYSA-N 0.000 description 1
- 241001530121 Trollius Species 0.000 description 1
- 240000001260 Tropaeolum majus Species 0.000 description 1
- 235000004424 Tropaeolum majus Nutrition 0.000 description 1
- HCHKCACWOHOZIP-UHFFFAOYSA-N Zinc Chemical compound [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 description 1
- 239000002250 absorbent Substances 0.000 description 1
- 230000002745 absorbent Effects 0.000 description 1
- 239000008351 acetate buffer Substances 0.000 description 1
- 150000007513 acids Chemical class 0.000 description 1
- 239000013543 active substance Substances 0.000 description 1
- 239000000654 additive Substances 0.000 description 1
- 239000000443 aerosol Substances 0.000 description 1
- 125000003158 alcohol group Chemical group 0.000 description 1
- 235000011399 aloe vera Nutrition 0.000 description 1
- 229940037003 alum Drugs 0.000 description 1
- XAGFODPZIPBFFR-UHFFFAOYSA-N aluminium Chemical compound [Al] XAGFODPZIPBFFR-UHFFFAOYSA-N 0.000 description 1
- 229910052782 aluminium Inorganic materials 0.000 description 1
- 235000012211 aluminium silicate Nutrition 0.000 description 1
- 229940101006 anhydrous sodium sulfite Drugs 0.000 description 1
- 230000000844 anti-bacterial effect Effects 0.000 description 1
- 229940121363 anti-inflammatory agent Drugs 0.000 description 1
- 239000002260 anti-inflammatory agent Substances 0.000 description 1
- 230000001153 anti-wrinkle effect Effects 0.000 description 1
- 125000003118 aryl group Chemical group 0.000 description 1
- 239000003212 astringent agent Substances 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- SRSXLGNVWSONIS-UHFFFAOYSA-N benzenesulfonic acid Chemical compound OS(=O)(=O)C1=CC=CC=C1 SRSXLGNVWSONIS-UHFFFAOYSA-N 0.000 description 1
- 229940092714 benzenesulfonic acid Drugs 0.000 description 1
- 238000004061 bleaching Methods 0.000 description 1
- 239000007844 bleaching agent Substances 0.000 description 1
- KDYFGRWQOYBRFD-NUQCWPJISA-N butanedioic acid Chemical compound O[14C](=O)CC[14C](O)=O KDYFGRWQOYBRFD-NUQCWPJISA-N 0.000 description 1
- 239000001110 calcium chloride Substances 0.000 description 1
- 229910001628 calcium chloride Inorganic materials 0.000 description 1
- 150000001732 carboxylic acid derivatives Chemical class 0.000 description 1
- 239000000919 ceramic Substances 0.000 description 1
- 229930183167 cerebroside Natural products 0.000 description 1
- 150000001784 cerebrosides Chemical class 0.000 description 1
- 229960000541 cetyl alcohol Drugs 0.000 description 1
- 239000000460 chlorine Substances 0.000 description 1
- 229910052801 chlorine Inorganic materials 0.000 description 1
- 230000001713 cholinergic effect Effects 0.000 description 1
- HNEGQIOMVPPMNR-IHWYPQMZSA-N citraconic acid Chemical compound OC(=O)C(/C)=C\C(O)=O HNEGQIOMVPPMNR-IHWYPQMZSA-N 0.000 description 1
- 229940018557 citraconic acid Drugs 0.000 description 1
- 238000004140 cleaning Methods 0.000 description 1
- 239000000701 coagulant Substances 0.000 description 1
- 239000011248 coating agent Substances 0.000 description 1
- 238000000576 coating method Methods 0.000 description 1
- 239000003086 colorant Substances 0.000 description 1
- 238000004040 coloring Methods 0.000 description 1
- 230000003750 conditioning effect Effects 0.000 description 1
- 238000001816 cooling Methods 0.000 description 1
- 239000006071 cream Substances 0.000 description 1
- 238000002425 crystallisation Methods 0.000 description 1
- 230000008025 crystallization Effects 0.000 description 1
- 208000031513 cyst Diseases 0.000 description 1
- ZAKOWWREFLAJOT-UHFFFAOYSA-N d-alpha-Tocopheryl acetate Natural products CC(=O)OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C ZAKOWWREFLAJOT-UHFFFAOYSA-N 0.000 description 1
- 239000002781 deodorant agent Substances 0.000 description 1
- 230000001419 dependent effect Effects 0.000 description 1
- 239000000645 desinfectant Substances 0.000 description 1
- 235000014113 dietary fatty acids Nutrition 0.000 description 1
- 210000002969 egg yolk Anatomy 0.000 description 1
- 239000003995 emulsifying agent Substances 0.000 description 1
- 210000002615 epidermis Anatomy 0.000 description 1
- 210000000981 epithelium Anatomy 0.000 description 1
- CCIVGXIOQKPBKL-UHFFFAOYSA-M ethanesulfonate Chemical compound CCS([O-])(=O)=O CCIVGXIOQKPBKL-UHFFFAOYSA-M 0.000 description 1
- BDWFYHUDXIDTIU-UHFFFAOYSA-N ethanol;propane-1,2,3-triol Chemical compound CCO.OCC(O)CO BDWFYHUDXIDTIU-UHFFFAOYSA-N 0.000 description 1
- 125000001301 ethoxy group Chemical group [H]C([H])([H])C([H])([H])O* 0.000 description 1
- 201000005884 exanthem Diseases 0.000 description 1
- 239000000194 fatty acid Substances 0.000 description 1
- 229930195729 fatty acid Natural products 0.000 description 1
- 239000000706 filtrate Substances 0.000 description 1
- 239000012467 final product Substances 0.000 description 1
- WBJINCZRORDGAQ-UHFFFAOYSA-N formic acid ethyl ester Natural products CCOC=O WBJINCZRORDGAQ-UHFFFAOYSA-N 0.000 description 1
- 235000021588 free fatty acids Nutrition 0.000 description 1
- FOYKKGHVWRFIBD-UHFFFAOYSA-N gamma-tocopherol acetate Natural products CC(=O)OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1 FOYKKGHVWRFIBD-UHFFFAOYSA-N 0.000 description 1
- 239000011521 glass Substances 0.000 description 1
- 229930182478 glucoside Natural products 0.000 description 1
- 150000008131 glucosides Chemical class 0.000 description 1
- 150000002321 glycerophosphoglycerophosphoglycerols Chemical class 0.000 description 1
- 150000002327 glycerophospholipids Chemical class 0.000 description 1
- 239000008187 granular material Substances 0.000 description 1
- 239000004519 grease Substances 0.000 description 1
- 239000000118 hair dye Substances 0.000 description 1
- 229910052736 halogen Inorganic materials 0.000 description 1
- 125000001475 halogen functional group Chemical group 0.000 description 1
- 150000002367 halogens Chemical class 0.000 description 1
- 230000005802 health problem Effects 0.000 description 1
- 238000010438 heat treatment Methods 0.000 description 1
- 239000001863 hydroxypropyl cellulose Substances 0.000 description 1
- 235000010977 hydroxypropyl cellulose Nutrition 0.000 description 1
- 229940071676 hydroxypropylcellulose Drugs 0.000 description 1
- 229960003943 hypromellose Drugs 0.000 description 1
- 230000002401 inhibitory effect Effects 0.000 description 1
- 238000011081 inoculation Methods 0.000 description 1
- 229960000367 inositol Drugs 0.000 description 1
- CDAISMWEOUEBRE-GPIVLXJGSA-N inositol Chemical compound O[C@H]1[C@H](O)[C@@H](O)[C@H](O)[C@H](O)[C@@H]1O CDAISMWEOUEBRE-GPIVLXJGSA-N 0.000 description 1
- 229910052742 iron Inorganic materials 0.000 description 1
- NLYAJNPCOHFWQQ-UHFFFAOYSA-N kaolin Chemical compound O.O.O=[Al]O[Si](=O)O[Si](=O)O[Al]=O NLYAJNPCOHFWQQ-UHFFFAOYSA-N 0.000 description 1
- 150000002576 ketones Chemical class 0.000 description 1
- 239000004310 lactic acid Substances 0.000 description 1
- 235000014655 lactic acid Nutrition 0.000 description 1
- 239000008101 lactose Substances 0.000 description 1
- 229940039717 lanolin Drugs 0.000 description 1
- 235000019388 lanolin Nutrition 0.000 description 1
- 239000007937 lozenge Substances 0.000 description 1
- VZCYOOQTPOCHFL-UPHRSURJSA-N maleic acid Chemical compound OC(=O)\C=C/C(O)=O VZCYOOQTPOCHFL-UPHRSURJSA-N 0.000 description 1
- 235000011090 malic acid Nutrition 0.000 description 1
- 229920000609 methyl cellulose Polymers 0.000 description 1
- 239000001923 methylcellulose Substances 0.000 description 1
- LXCFILQKKLGQFO-UHFFFAOYSA-N methylparaben Chemical compound COC(=O)C1=CC=C(O)C=C1 LXCFILQKKLGQFO-UHFFFAOYSA-N 0.000 description 1
- 239000010445 mica Substances 0.000 description 1
- 229910052618 mica group Inorganic materials 0.000 description 1
- 239000002480 mineral oil Substances 0.000 description 1
- 235000010446 mineral oil Nutrition 0.000 description 1
- 238000002156 mixing Methods 0.000 description 1
- GOQYKNQRPGWPLP-UHFFFAOYSA-N n-heptadecyl alcohol Natural products CCCCCCCCCCCCCCCCCO GOQYKNQRPGWPLP-UHFFFAOYSA-N 0.000 description 1
- 229910052759 nickel Inorganic materials 0.000 description 1
- 229910017604 nitric acid Inorganic materials 0.000 description 1
- JCXJVPUVTGWSNB-UHFFFAOYSA-N nitrogen dioxide Inorganic materials O=[N]=O JCXJVPUVTGWSNB-UHFFFAOYSA-N 0.000 description 1
- 150000007524 organic acids Chemical class 0.000 description 1
- 235000005985 organic acids Nutrition 0.000 description 1
- 235000006408 oxalic acid Nutrition 0.000 description 1
- 238000012856 packing Methods 0.000 description 1
- 229940101267 panthenol Drugs 0.000 description 1
- 239000011619 pantothenol Substances 0.000 description 1
- 235000020957 pantothenol Nutrition 0.000 description 1
- 239000012188 paraffin wax Substances 0.000 description 1
- 230000036961 partial effect Effects 0.000 description 1
- 230000035515 penetration Effects 0.000 description 1
- 239000003961 penetration enhancing agent Substances 0.000 description 1
- 229940066842 petrolatum Drugs 0.000 description 1
- 235000019271 petrolatum Nutrition 0.000 description 1
- 239000000546 pharmaceutical excipient Substances 0.000 description 1
- NBIIXXVUZAFLBC-UHFFFAOYSA-K phosphate Chemical compound [O-]P([O-])([O-])=O NBIIXXVUZAFLBC-UHFFFAOYSA-K 0.000 description 1
- 239000010452 phosphate Substances 0.000 description 1
- WTJKGGKOPKCXLL-RRHRGVEJSA-N phosphatidylcholine Chemical compound CCCCCCCCCCCCCCCC(=O)OC[C@H](COP([O-])(=O)OCC[N+](C)(C)C)OC(=O)CCCCCCCC=CCCCCCCCC WTJKGGKOPKCXLL-RRHRGVEJSA-N 0.000 description 1
- 229920000573 polyethylene Polymers 0.000 description 1
- 229920001223 polyethylene glycol Polymers 0.000 description 1
- 229920000151 polyglycol Polymers 0.000 description 1
- 239000010695 polyglycol Substances 0.000 description 1
- 239000000244 polyoxyethylene sorbitan monooleate Substances 0.000 description 1
- 235000010482 polyoxyethylene sorbitan monooleate Nutrition 0.000 description 1
- 239000001818 polyoxyethylene sorbitan monostearate Substances 0.000 description 1
- 235000010989 polyoxyethylene sorbitan monostearate Nutrition 0.000 description 1
- 229940113124 polysorbate 60 Drugs 0.000 description 1
- 229940068968 polysorbate 80 Drugs 0.000 description 1
- 229920000053 polysorbate 80 Polymers 0.000 description 1
- 229910000027 potassium carbonate Inorganic materials 0.000 description 1
- 230000002335 preservative effect Effects 0.000 description 1
- 239000006041 probiotic Substances 0.000 description 1
- 230000000529 probiotic effect Effects 0.000 description 1
- 235000018291 probiotics Nutrition 0.000 description 1
- 239000003380 propellant Substances 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 206010037844 rash Diseases 0.000 description 1
- 238000001953 recrystallisation Methods 0.000 description 1
- 238000010992 reflux Methods 0.000 description 1
- 239000012047 saturated solution Substances 0.000 description 1
- CDAISMWEOUEBRE-UHFFFAOYSA-N scyllo-inosotol Natural products OC1C(O)C(O)C(O)C(O)C1O CDAISMWEOUEBRE-UHFFFAOYSA-N 0.000 description 1
- 238000010956 selective crystallization Methods 0.000 description 1
- 229940076279 serotonin Drugs 0.000 description 1
- 238000007873 sieving Methods 0.000 description 1
- 239000000377 silicon dioxide Substances 0.000 description 1
- 235000012239 silicon dioxide Nutrition 0.000 description 1
- 239000002356 single layer Substances 0.000 description 1
- 210000003625 skull Anatomy 0.000 description 1
- 239000000344 soap Substances 0.000 description 1
- ODZPKZBBUMBTMG-UHFFFAOYSA-N sodium amide Chemical compound [NH2-].[Na+] ODZPKZBBUMBTMG-UHFFFAOYSA-N 0.000 description 1
- GEHJYWRUCIMESM-UHFFFAOYSA-L sodium sulfite Chemical compound [Na+].[Na+].[O-]S([O-])=O GEHJYWRUCIMESM-UHFFFAOYSA-L 0.000 description 1
- 239000001587 sorbitan monostearate Substances 0.000 description 1
- 235000011076 sorbitan monostearate Nutrition 0.000 description 1
- 229940035048 sorbitan monostearate Drugs 0.000 description 1
- 210000000952 spleen Anatomy 0.000 description 1
- 239000007921 spray Substances 0.000 description 1
- 239000003381 stabilizer Substances 0.000 description 1
- 239000004575 stone Substances 0.000 description 1
- 239000011593 sulfur Substances 0.000 description 1
- 229910052717 sulfur Inorganic materials 0.000 description 1
- 230000000153 supplemental effect Effects 0.000 description 1
- 239000000375 suspending agent Substances 0.000 description 1
- 230000035900 sweating Effects 0.000 description 1
- 239000003826 tablet Substances 0.000 description 1
- 239000004408 titanium dioxide Substances 0.000 description 1
- JOXIMZWYDAKGHI-UHFFFAOYSA-N toluene-4-sulfonic acid Chemical compound CC1=CC=C(S(O)(=O)=O)C=C1 JOXIMZWYDAKGHI-UHFFFAOYSA-N 0.000 description 1
- 238000011200 topical administration Methods 0.000 description 1
- VZCYOOQTPOCHFL-UHFFFAOYSA-N trans-butenedioic acid Natural products OC(=O)C=CC(O)=O VZCYOOQTPOCHFL-UHFFFAOYSA-N 0.000 description 1
- 150000003626 triacylglycerols Chemical class 0.000 description 1
- 229940099259 vaseline Drugs 0.000 description 1
- 235000008979 vitamin B4 Nutrition 0.000 description 1
- 239000011579 vitamin B4 Substances 0.000 description 1
- 238000009736 wetting Methods 0.000 description 1
- 235000020985 whole grains Nutrition 0.000 description 1
- 239000011701 zinc Substances 0.000 description 1
- 229910052725 zinc Inorganic materials 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/49—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
- A61K8/4973—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with oxygen as the only hetero atom
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/49—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
- A61Q19/008—Preparations for oily skin
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
- C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
- C07D231/10—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D231/12—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
- C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
- C07D233/56—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D249/00—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
- C07D249/02—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
- C07D249/08—1,2,4-Triazoles; Hydrogenated 1,2,4-triazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
- A61Q19/08—Anti-ageing preparations
Landscapes
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- Birds (AREA)
- Epidemiology (AREA)
- Dermatology (AREA)
- Cosmetics (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Massaging Devices (AREA)
- Finger-Pressure Massage (AREA)
- Plural Heterocyclic Compounds (AREA)
- Agricultural Chemicals And Associated Chemicals (AREA)
- Metal-Oxide And Bipolar Metal-Oxide Semiconductor Integrated Circuits (AREA)
- Polysaccharides And Polysaccharide Derivatives (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Description
A6 B6
五、發明説明(1 ) 人的價值面在於其皮虜的外觀,一種油腻的皮虜,如 經過忙碌的一天或運動過後,通常被轻T為是惱人的,即 使此是暫時且並不表示任何健康的問題,本發明係有醑 使用供調節皮廉油脂性之藥劑,尤其是所述藥剤新穎的 物理型式,包含所述藥劑之化粧品組合物,製備所逑藥 劑及組合物之方法及調節皮虜油脂性之方法。 本發明镍有關使用具下式化合物,其中R表甲基或乙 V
0 、 II N-C-0-R (順式)-(I ) 基,較佳地是乙基,或其化粧品可接受之酸加成鹽,以 調節人類皮麝之油脂性之用途。 '本發明亦有關調節人類皮虜油脂性之方法,其包括將 具式(順式)-(1)之化合物,或其化粧品可接受之酸加 成鹽,以足夠調節皮虜油脂性之量局部投予至所述人們 之皮廉。 化合物(I)可施用至皮廉,當需要或方便,如在每次 冲洗時或之後,可重覆局部投藥直至得到化粧品有益滅 -----------------「-----r I 裝 J-----.^!----^ Λ s V" (請先閱讀背面之;1-寧項再Μ寫本頁) 經濟部中央標準局8工消費合作社印*''取 低皮_之油脂件.當IE常丨吏用化!Η藥勘j #,^ ^ # S'J 6¾ .11. ―*1* 丨· Ta πα ο 用於本發明方法之式(I )化合物,(± )順式-4 -〔 4 - 衣紙張尺度通用中國國家標準(CNTS)甲4规格(210 X 297公货〉 ^〇〇H6
A6 B6 五、發明説明(2 ) 〔〔2- (2, 4-二氛苯基)-2-( 1H-眯唑-1-基-甲基)- 1, 3 -二氣戊烷-4-基〕甲氣基]苯基广-卜六氫吡阱羧 酸甲酯或乙酯是之藥上,且^製備及質)已掲示於 U S - ^ , 3 3 5 , 1 2 5 „ 目前情況較隹地是使用式(I )化合物或其化粧品可 接受之酸加成鹽,所述之鹽類可方便地以適當的酸處理 鹼而製備,如氳鹵酸,如鹽酸或氫溴酸;硫酸;硝酸; 磷酸等;或有機酸如乙酸,丙酸,羥乙酸,2-羥基-丙 基,2-氣丙酸,乙二酸,丙二酸,丁二酸,(Z)-2-丁烯 二酸,(E)-2-丁烯二酸,2-羥基丁二酸,2, 3-二羥基 丁二酸,2-羥基-1, 2, 3-丙三酸,甲烷磺酸,乙烷磺 酸,苯磺酸,4-甲苯磺酸,環己烷胺基磺酸,2-羥基苯 甲酸,4-.胺基-2-羥基苯甲酸等酸。 (婧先間汸背面之注念事項再螭寫本頁) 其, 及是 }例 I ί "實 物之 合物 化合 含劑 包溶 亦述 詞~所 名7~ 個1物 造合 鹽劑 成溶 加之 酸成 用形 使可 所鹽 述成 前加 酸 層 上 皮 表 於 位 到 合 结 可 且 的 素 〇質 等角 物親 合是 醇} I , (. 物物 合 合 水化 如 經濟部中央標準局8工消脅合作社印製
本紙張尺度適用中國國家標準(CNS)甲4规格(210 X 297公釐) A6 B6 五、發明説明(3 ) 述游離脂肪酸的組成,化合物(I)亦影鬱磷脂質 在皮虜上的濃度,除了影礬脂質含量外'式(I)化合物 在使用濃度時亦可對撤生物的生長産生一些抑制作用, 如细薗及徽菌〇 由於所述徹生物是依賴存在皮虜上之脂質,化合物 (I)對皮虜脂質含量及撤生物生長的雙重作用,確使皮 廉上的菌落被抑制且没有不良味道的産生。 化合物(I )可依掲示在US-4,335, 125之方法製備,或 較佳地可由順式-1-乙醯基-4-〔4-〔 〔2- (2, 4 -二氣 苯基)-2-(1Η-眯唑-1-基甲基)-1, 3-二氣戊烷-4-基 〕甲氣基〕苯基〕六氫吡阱(Π )(其是一商品)而製得 ,特別是,化合·物(I )可由水解順式-1 -乙篚基-4 -〔 4 -〔 〔2-(2, 4-二 氯苯基 ) -2-(1Η-咪唑 -1-基甲基 ) - 1, 3 -二氣戊烷-4-基〕甲氣基]苯基〕-六氫毗阱(1丨) ,’並將所得之産物與式W-C( = (l)-0-R (III)反應而製備, 其中R表甲基或乙基及W表離去基如鹵素,較佳地氯, 甲氧基或乙氧基。 (琦先閱为背面之注*事頊再填寫本頁)
丨裝JI f 經濟部中央標準局員工消費合作社印*'1*·
00 水解 0) 〇 2. W-C(=0)-0-R /\ π N N-C-CH3 ⑽ 所述的水解可方便地將順式-1 -乙醯基-4 -〔 4 - 5 - 2 - 本纸張尺度通用中國國家標準(CNS)甲4规格(210 X 297公釐) A6 _B6_ j 五、發明説明() (2,4-二氛苯基)-2-(1Η-眯唑-1-基甲基)-1, 3-二 氧戊烷-4-基〕甲氣基〕苯基〕六氳吡胼(II) /水之溶 液於齡或酸存在下,較佳地在濃鹽酸存在下攪拌及加熱 而進行,水解産物由反應混合液中(以鹼如氫氣化鈉或 鉀中和)以有機溶劑萃取,如鹵化烴,如二氣甲烷,或 醇類,如甲醇,乙醇等,或這些溶劑的混合液,有機層 蒸乾後,粗的水解産物無需純化,可直接溶於鹵化烴中 ,如二氮甲烷,並於鹼如碩酸納或鉀存在下,以氣甲酸 甲酯或乙酯處理而轉化成化合物(I),攪拌混合液可加 速反應速率,且反應可方便地在室溫下進行。 在依本發明之方法中,有利的是使用徹粒型式之化合 物(I ),尤其是·具平均顆粒尺寸小於1 #之物質,較 佳地小於7 5 a ,且特別是平均顆粒尺寸不超過1 5 #。 微粒型式之化合物(I)由於其高表面積,具有較佳且 較快溶解及較佳穿透表皮上層之優點,化合物I之徹粒 型式是新穎的且可以此技S中已知之微粒技術製備,如 以適當之磨研磨並通過適當的篩子過篩。 經濟部中央標苹局S工消費合作社印製 (諳先《为背面之:}£*事頊再場寫本頁) 化合物(I)之游離鹼,其中R表乙基存在二種多形型 式;較高熔點之多形體I本質上是結晶純質物質,其可 以DSC在約127 . 6°C具最大尖峰而持歡化;較低熔點之多 形體I[是結晶純質物質,可以其在約1 1 ϋ . 9 °C有最大尖 峰而待獻化,多形體I較多形體丨I安定但較不易溶解, 且是在依本發明方法中較佳使用之多形型式。 -6 - 本纸張尺度通用中國國家標準(CNS)甲4規格(210 X 297公货) 經濟部中央標準局8工消費合作社印製 A6 B6 五、發明説明(5 ) 多形體(I )可方便地將游離龄型式之化合物(I )在適 當溶劑如酮或酯類中再结晶而製備,如^丙_或酸乙酯, 所述之再结晶通常包括將游離鹼型式之式(I )化合物溶 於熱溶劑中,將所得溶液濃缩,令濃縮液冷卻並分離沉 潑出的结晶,較佳地,溶液在濃縮前以活性碩處理,再 者,在欲结晶的多形髏I超飽合溶液中接種由先前批次 中所獲得所述多形體I之適當晶體,可能是有益的,多 形體I可以前述掲示方法在適當磨中研磨並將所得産物 過篩而撤粒化,例如使用適當篩子如10Q及74//篩孔之 氣體一噴射篩子》 另一方面,多形體II可將化合物(I)之游離鹼在適當 溶劑中如2 -丙酵,己烷或甲苯中再结晶而獲得。 所述多形體Π之選擇性結晶可由所欲結晶之多形體Π 的超飽含溶液中接種而誘生,多形體Π也可微粒化,但 需小心以避免多形體II轉化成多形體I。 化合物I最佳的是以適當組合物之型式施於身體受影 锻的部位,尤其是以化粧品組合物,所述組合物包含化 合物(I),較佳地以0.05¾〜1 %之濃度(重量對重量) ,尤其是0.1¾〜0.5¾之濃度,特別是0.1¾〜0.2¾之濃度 ,及任何已知皮唐之可接受載體,所述組合物可以各種 不同的型式如液態,如溶液,乳劑,嘐或在水溶液,醇 或油介質之懸浮劑,如化粧水,髮乳,洗劑,皮莆乳或 乳狀洗割及洗髮精;或半液態配方,如乳# ,水_ ,膠 衣紙張又度通用中國國家標準(CNS)甲4规格(210 X 297公釐) (琦先閱为背面之ixt事項再項寫木頁) -·——裝· 訂· A6 B6 經濟部中央標準局8工消費合作社印製 五、發明説明(6 ) ,糊音,軟音, 所逑裂劑除了 成份,這些成份 濕潤劑,增滲劑 稠安定劑,螯合 染料,低级酵, 可併入组合物中 傷劑,消毒劑, 化合物(I )有 理不潔的皮廉或 丘疹等,這些化 期間或之後所使 褐化的産品,皮 清潔及保護的衛 ‘品,刮鬍眘,泡 身的衛生照顧産 粧製劑如乳胥, 著色乳膠,面霜 ,科隆香水,脱 ,著色基劑,粉 去化粧品之産品 變直及固定之産 品或理髮産品; 蕾 藥 酊 劑 等 f 或 固 化 合 物 (I )外 9 包 含 之 實 例 是 油 > 脂 肪 > > 稠 化 劑 > 脂 質 吸 收 劑 9 缓 衝 劑 , 防 腐 劑 不 飽 合 醇 等 t 若 需 要 i 如 抗 發 炎 劑 > 抗 菌 維 生 素 » 濾 光 劑 > 抗 益 的 用 於 化 粧 産 品 > 預 防 皮 虜 發 展 出 不 潔 粧 品 組 合 物 之 實 例 是 用 之 保 護 B m 産 品 9 廉 一 漂 白 産 品 ί 抗 皺 生 製 劑 如 肥 皂 > 洗 髮 沫 或 洗 劑 嬰 兒 保 護 品 如 貼 身 的 清 潔 産 品 乳 剤 膠 * 油 9 洗 劑 除 臭 劑 } 抗 __. 出 汗 毛 劑 » 刮 m 後 用 之 香 劑 > Π 红 9 面 胥 J 眼 護 髮 産 品 如 染 髮 及 品 f 作 髮 形 之 産 17J 及 其 他 化 粧 産 品 〇 體 配 方 如 粉 劑 〇 常 用 於 這 些 製 劑 之 蟠 > 界 面 活 性 劑 S 劑 9 抗 氧 化 劑 9 粘 > 香 料 • 芳 香 劑 > 9 其 他 活 性 成 份 也 劑 * 抗 徽 m 劑 1 癒 生 素 或 抗 頭 皮 屑 劑。 其 是 有 用 的 用 於 處 物 如 污 點 » 粉 刺 9 曝 露 在 陽 光 之 前 > 無 需 曰 鼷 而 使 皮 虜 紋 産 品 » 每 B 用 來 精 » 洗 澡 及 沐 浴 産 産 品 f 衛 生 紙 » 阽 » 及 每 天 使 用 的 化 » 皮 虜 乳 乳 膠 > 劑 ) 香 水 > 化 粧 水 水 i 化 粧 品 如 乳 胥 線 > 由 臉 或 眼 睛 除 漂 白 » 用 於 捲 髮 t 清 潔 産 品 » 調 理 産 (諳先閱为背面51£*事項再場寫本頁) -丨裝, 訂· 表紙張尺及通用中國國家標準(CNS) 甲4规格(210 X 297公釐) 經濟部中央標準局β工消費合作社印製 A6 B6_ 五、發明説明(7 ) 液髏裂劑可方便地以任何適於局部投予之調配裝置包 装,例如似香水瓶的小瓶,瓶子或噴瘃罐,其是以惰性 壓缩氣體作為推動劑如氮氣或二氧化碩,或選擇地使用 幫浦以裂成氣霧罐,固鱧製劑可以粉撲或面音直接施用 至皮虜,替代地,固體製劑如顆粒,錠劑或粉末也可溶 於浴缸中,半液體製劑可包裝在適當.的,習知容器如塑 膠,玻璃或陶瓷罐,管,如PVC—包覆之鋁管。 其他特殊的組合物是那些其中化合物(I )配製在含脂 小體的組合物,可使用不同型式的脂小體,如粗的(多 層)脂小體或單層脂小髏等,其是使用如甘油磷醛膽素 、乙醇胺、絲胺酸,神經磷脂,cardiolipins, plasraalogens,' 碟脂酸,cerebrosides等,脂小鱧的粘 掘度可加入一或多種稠化劑如黃蓍膠,羥丙基纖維素, 經丙基甲基纖雒素及其混合物而增加,液體組成可包含 τΚ,任意地與電解質,缓衝劑及其他成份如防腐劑混合 ,較佳的電解質是氯化鈣、鈉及鉀,有機組成份可包含 溶劑如乙醇,甘油,丙二醇,聚乙二醇,及適當的磷脂 質如蛋黃素,膽素甘油磷脂,乙醇胺甘油磷脂,絲胺酸 甘油碟脂,肌醇甘油碟脂,lysophosphatidyl choline ,甘油磷脂等,可加入其他親脂性添加物以選擇地修飾 脂小體的特性,如十八胺,磷脂酸,雒生素E ,膽固醇 ,羊毛脂等。 欲製備軟資,乳苷,化粧水,皮慮乳劑等,化合物(I ) 本紙張度適用中國國家標準(CNS)甲4规格(210 X 297公釐) (請先閑背面之;£«-?事項再鸠寫本頁)
T ,裝· 經濟部中央標準局8工消費合作社印製 A6 _B6_ f 五、發明説明(8 ) 是與化粧品可接受載劑混合,在軟音或乳資,載體例如 包含1〜20¾,尤其是5〜15¾之濕潤劑,、0.1〜10%,尤其 是0.5〜5%之稠化劑,及水;或所述之載體可包含70〜 99%,尤其是8 (ί〜95 %之界面活性劑,及0〜20%,尤 其是2.5〜15¾之脂肪;或80〜9 9.9% ,尤其是90〜99% 之稠化劑;或5〜1 5 %界面活性劑,2〜1 5 %濕潤劑,0 〜80%油,十分少量(0〜<2%)之防腐劑,箸色劑及/或 芳香劑,及水,在化粧水,載饅例如包含2〜10 %低级醇 ,0.1〜10%或尤其是0.5〜1 %界面活性劑,1〜2(U,尤 其是3〜U濕潤劑,0〜5 %缓衝劑,水及十分少量(0〜< 2 3:)之防腐劑,染料及/或芳香劑,在乳膠,載體典型地 包含50〜80%水,較佳的70〜80%水;8〜20%,較佳 的10〜15%醇;1〜10%,較佳的2〜5%界面活性劑; 0 . 5〜2 % —或多種稠化割;及0〜3 %防腐劑,濕潤劑, 誉養因子,維生素,收斂劑及/或芳香劑,其他可併入 之活性成份是劑量在0.005%〜Q.5¾.尤其是0.01%〜0.1 % 〇 典型的乳膠製劑包含前述濃度的活性成份;水;一或 多種凝_劑或稠化劑如織雒Μ素衍生物,如羥丙基織維 素,羥丙基甲基纖雒素,或羧乙烯聚合物,以0.02 %〜 4 %之濃度,尤其是0 . 2 %〜2 %且較佳的約I) . 2 %〜1 . 5 % ; —或多種醇類如乙醇,丙醇,丁醇,戊醇,甘油, 丙二醇,十二磺三烯醇,以0 . 0 2 %〜5 0 %之濃度,尤其 -1 0 - {請先閲讀背面之;i*事項再蜞寫本頁)
A •裝. .π. 本紙張尺度通用中國國家標準(CNS)甲4规格(210 X 297公釐) A6 B6 五、發明説明(9 ) (請先閲讀背面之·;±5事項再塡寫本頁) 是0.5%〜3(3%且較佳的約0.5%〜20%,所述典型的乳 藤裂劑可進一步包含植物萃取物如來自'蘆薈,山金車, 白樺,囊海草,龍臛,人參,金縷梅(巫榛),山楂, 肯納(kina),檸樣,金蓮花,迷迭香等,以0.U〜35 % 之濃度,較佳的0 . 5 %〜1 2 %且丨寺別是13:〜3 S!;油成份 如凡士林,、以〇 . U〜3 0 %之濃度,較佳的0 . 2 %〜1 0 %且 特別是1%-53!;維生素如維生素E (生育醇)及其衍生 物,如乙酸生育醇酯,?&111;11611〇1等,以0.01:15〜10%之 濃度,較佳的0 . 1 %〜8 %且特別是0 . 5 %〜2 % ;合成或 天然來源之抗發炎藥,如bisaboloi,以0¾〜5¾之濃度 ,較佳的0.U〜3¾且持別是0.2%〜0.5%;芳香劑,以0¾ 〜2 %之濃度,較佳的0 . 1 %〜U且特別是0 . 3 %〜0 . 5 % :及 足以防止最終組合物分解之量之任意的防腐劑及/或抗 氧化劑。 '典型的染色製劑可為包含前述嬝度活性成份之乳劑; 水,一或多種乳化劑郎乙氣化脂肪醇,如c e t e c h , laueth, rayreth, oleth, steareth, trideth,以 0.1% 〜1 0 %之濃度,較佳的〇 . 5 %〜5 % ; —或多種脂肪成份 如C 8 - 22脂肪醇,較佳的C 12 _ 1S脂肪醇,以0 · 1 %〜1 0 經濟部中央標準局8工消費合作社印製 %之濃度,較佳的〇 . 5 %〜5 % ,或碾油(軟石蟠),以 0.U〜80%之濃度,較佳的U〜30%;或聚氣乙基或丙基 脂肪醇如聚氣丙基硬脂Μ ,以1〜4 0 %之濃度,較佳 的5〜3 ϋ % ,且待別是1 0〜2 0 % ; —或多種醇類如乙gf, -1 1 - 本紙張尺度迺用中國國家缥準(CNS)甲4规格(210 X 297公釐) ^00166 ^00166 經濟部中央標準局貝工消费合作社印製 A6 _B6_ r x 五、發明説明(10) 丙醇,丁醇,戊醇,甘油,丙二醇,丁二醇,十二碩三 烯醇,以0.U〜25¾之濃度,較佳的0.飞5:〜203:,所述染 色製劑明顯地可進一步包含一或多種色素如氣化鋅,高 嶺土,雲母,氣化鐵,二氣化鈦等,所逑染色製劑亦可 再進一步包含植物萃取物,如來自蘆薈,山金車,白樺 ,囊海草,龍膽,人參,金縷梅(巫榛),山楂,肯納 (kina),檸樣,金蓮花,迷迭香等,以0.1;?〜35¾之濃 度,較佳的0.5¾〜12%且待別是U〜3:ϋ;凝膠劑如绻雒 素衍生物或羧乙烯聚.合物,以濃度0.U〜U;維生素如 維生素Ε (生育醇)及其衍生物如乙酸乙育醇酯, panthenol等,以0.01¾〜10¾之濃度,較佳的0.U〜8¾ 且尤其是0.5%〜25ϋ;合成或天然來源之抗發炎藥,如 以3&1)〇1〇1,以0:«〜5%之濃度,較佳的0.1%~3;!;且尤其 是0 . 2 %〜0 . 5 ίϋ ;稠化劑如黃蓍膠,以0 · 1 %〜1 %之濃度 特別是〇 . 2 %〜0 . 5 % ;芳香劑,以0 %〜2 %之濃度,持別 是0.1¾〜U且尤其是0.3%〜0.5%;及足以防止最终組合 物分解之量之任意的防腐劑及/或抗氧化劑,前述製劑 較佳地具PH 5〜7.5,特別是5. 5〜7,所述pH可加入鹾 如氫氣化鈉,或酸如乳酸,檸樺酸或磷酸,或缓衝劑如 檸樣酸鹽,磷酸鹽,乳酸鹽或醋酸鹽缓衝液而建立。 典型的面資製劑包含前述濃度之活性成份;一或多種 脂肪物質如礦油(軟石蠟),以U〜7 0 %之濃度,較佳 的3 0 % ~ 6 0 5;,或凡士林,以0 . 1 3ί〜3 (U之濃度,較佳的 -1 2 - 本紙張尺度適用中國國家標準(CNS)甲4規格(210 X 297公货) 1 n 1 n In n n 11 n» I - I I I -- i-i n I ! n - n L·. I m · I— n XI I I- -- - - - -I - i n It (請先閲twc面之注意事i?再填寫^頁) 經濟部中央標準局β:工消費合作社印製 A6 _B6_ ( 五、發明説明(11) 5¾〜2〇χ;三酸甘油酯,以Q.U〜3〇χ之醆度,較佳的ΐϋί 〜103:;脂肪C8 -22醇,較佳的C!2- Is脂肪醇,以0.1 3{〜4 03;之濃度,較佳的1 %〜1 0 S!;蟠,以0 . 13!〜1 (U之濃 度;及任意地足以防止终産物分解之置之防腐劑及/或 抗氣化劑;及任意地其他成份如芳香劑,癒傷劑,色素 等〇 在前述製劑中,所有的%符號表重量對重最百分比, 在所述製劑中之濕潤劑,界面活性劑,油,其他活性成 份等可為化粧品界中所使用之任何成份,再者,當在前 述组合物中一或多種成份構成組合物之主要部分時,其 他成份明顯的可不存在其所示之最大濃度且因而構成組 合物之剩餘部份。 「奮驗部份1 實例1 :製備化合物(I ) ’a )—含5 0克順式-卜乙醛基-4 -〔 4 - C 〔 2 - ( 2 , 4 -二氛 苯基)-2-(1Η-眯唑-1-基甲基)-1, 3-二氧戊烷-4-基 〕甲氧基〕苯基〕六氫吡阱,105克水及35克濃鹽酸之 經攢拌混合物在80〜90°C下加熱16小時,反應混合物冷 卻至室溫(約20-25 °C)並加人70ml二氣甲烷及30ml甲 醇,攪拌下逐滴加入2 5 κ 1氫氧化鈉溶液(5 0 %在水中) ,並在冰水中冷卻以維持反應混合物之溫度低於3 G °C , 攪拌半小時後,加入另外1 3 0 m 1二氯甲烷及1 7 0 m 1甲醇, 再持鑀It伴半小時,分離有機層並在減壓下蒸除有機溶 -1 3 - (請先HtMsr面之注意事項再填寫本頁)
ILI 裝 J 訂. f 本紙張尺度通用中國國家標準(CNS)甲4.規格(210 X 297公货) 經濟部中央標準局8工消費合作社印製 A6 _B6_ 五、發明説明(12 ) 劑,殘留物溶於200ml二氣甲烷。 b) 將52克碳酸鉀及12.25克氣甲酸乙酯~(逐滴)加入殘 留物中,並雒持反應溫度低於25 °C,在室溫攪拌2小時 後,加入112克水並再連缠播拌4小時,分離有機層, 乾燥,過濾並在減壓下蒸乾,加熱將殘留物溶於60ml 4-甲基-2-戊嗣,結晶是令反應混合液自勤冷卻至室溫 ,再以冰水冷卻4小時後,濾出沉澱物並在4 0 °C ,真空 下乾燥,可得44_84克(84.93Π之(±)順式-4-〔4-〔〔 2-(2,4 -二氣苯基)-2-(1Η -昧睡_1-基甲基)-1, 3 -二氣戊烷-4-基]甲氧基〕苯基〕-1-六氫吡阱羧酸乙 酯。 c) 6.5 克(±)顒式-4-〔4-〔 〔2-(2, 4-二氣苯基)-2- (1H -咪唑-1-基甲基)-1, 3 -二氣戊烷-4-基]甲氣基 〕苯基〕-卜六氫吡畊羧酸乙酯/51.5 m义丙酮混合液加熱 1迺流溫度,而後加入3 . 2 3克活性磺(N 〇 r i t A s u p r a ) ,再迴流半小時後,反應混合液趁熱通過矽藻土過濾, 過濾介質以熱丙酮冲洗,將所收集的濾液濃缩至約25ml 之终體積,令反應混合液冷卻4 0°C ,而後以多形體I接 種,令反應混合液再冷卻至室溫,而後以冰水冷卻攢拌 1小時,濾出沉澱物並在4 (TC ,真空下乾燥,可得5 . 3 5 份(8 2 . U )之(± )順式-4 -〔 4 -〔 〔 2 - ( 2 , .4 -二氣苯基 )-2-( 1H -眯唑-1-基甲基)-1, 3 -二氣戊烷-4-基〕甲 氣基〕苯基]-1 -六氫吡阱羧酸乙酯(多形體I ); -1 4 - ---------------------裝 J-----trl —----f 丨 (請先聞面之注意事*»*再*^頁) 本紙張尺度迺用中B國家標準(CNS)甲4规格(210 X 297公釐) A6 B6 經濟部中央標準局Η工消費合作社印製 五、發明説明(13 ) m . p . 1 2 7 . 6 Ό 0 Γ部会物奩俐] 、 下列製劑例示依本發明之典型組合物。 這些實例中所用之”活性成份” (A.I.)是有關式(I) 化合物或其化粧品可接受之酸加成馥。 音例2 : 0 . 1 $乳薔 將75m g硬脂醇,2 mg十六醇,20m g己六醇内醚單硬脂 酸酯(Sorbitan monostearate)及10 ng肉豆蔻酸異丙酯 導入雙層夾套容器中並加熱直至混合物完全熔化,將此 混合物加入另外配製具70〜75 °C含純水,200 mg丙二醇 及15mg polysorbate 60之混合液中,並以研磨機研磨 成液體,令所得之乳劑持缋混合並冷卻至低於2 5 °C ,在 持缅播伴下先後加入含lmg A.I., lag polysorbate 80 及純水之溶液及2 mg無水亞硫酸鈉/純水溶液,乳蕾绖 研磨並充填入適當的管子中I ~ g例: 0 . ? ϋ;脂小鵲Μ酬 將含0.2克Α.Ι.微粒,20克膽素甘油磷脂,5克膽固醇 及10克乙醇之混合液在55-60 °C攢拌並加熱,直至完全 溶解,而後在研磨下加至含0.2克羥基苯甲酸甲酯,0.02 克羥基苯甲酸丙酯,0.15克乙二胺四醋酸二納及0.3克 氨化鈉/純水之溶液中,加入0 . 1 5克羥丙越甲基纖維素 /加水至1 0 0克並持續混合直到完全膨脹。 啻俐4 : 0 . 1 %脂小騁製劑 -1 5 - (請先閲HMc面之注意事项再本頁) -. —裝. 訂_ 本紙張尺度迺用中國國家標準(CNS)甲4规格(210 X 297公货) ^Οΰΐβύ Α6 Β6 五、發明説明(14) 在4Q°C將含1ϋ克臛素甘油 乙醇攪拌並加熱直到完全溶 加熱下邋拌溶於純水中,在 加至水溶液中,在攪拌下加 /純水,直至完全膨脹,所 至Pfl 5,並以其餘的水稀釋 磷脂及1克瞻固醇/ 7. 5克 解,0.2克3.1.徹粒在40 °C 10分鐘内研磨下將醇溶液慢 入1.5克羥丙基甲基纖維素 得的溶液以1 N氫氧化鈉諝整 至1〇〇克β (猜先閲泠背面之;±舟?寧頊再蜞寫本頁) t ---裝· 訂.
A 經濟部中央標準局8工消費合作社印製 本紙張尺度迺用中國國家標準(CNS)甲4规格(210 X 297公釐> 3_Ue 8V2:^修正 : 广 -.1·'' A6 k B6 五、發明説明() 專利申請案第82102065號 ROC Patent Appln. No. 82102065 補充之細資料中文本-附件㈢ Supplemental Test Data in Chinese - EncL (III) (民國82年12月/日送呈) (Submitted on December / , 1993) 皮脂分泌逡丰 14位健康之志頋者參與下述之試驗。 將賦形施用於额頭之右側,並將含有0.5 %(±)蟵 式-4-[4-[[2-(2,4-二氣苯基)-2-(111-咪唑-1-基-甲 基)-1,3-二氧戌垸-4-基]甲氧基]苯基]-卜六氳晚畊 羧酸乙睹之賦形劑施用於额頭之左倒,施用之次數係 每天一次。於開始試驗後之〇週,3遇,6週,9週 及12遇後測定皮脂分泌速率。 於6遇後測出了皮脂分泌平均降低10-20%,且於實 驗接下來的6遇期間此一皮脂分泌降低水平可再繼績 維持。 (請先wf面之注項再«寫本賈) —裝. 訂-
X 經濟部中夹標準曷Λ工消费合作社印笨
93-9jansen.l080-Y ^纸张尺度通用中钃國家標华(CNS)肀4规格(210 X 2OT公釐> 82.6. 40,000
Claims (1)
- 申請專利範困 專利中轉案第82l〇2〇65tt ROC Patent Appln. No.82102065 ~84年3另V曰进星)— (^uSaitted on March 4了, 19§5) 1.一種減低皮廣油腐性之化粧品銥合物,其包含化粧 品载«及式(I)化合物或其化粧品可接受之酸加成重 做爲活性成份0 " N一C 一Ο 一 R (顒式)-(I ) (請先閲讀背面之注$項再填寫本頁) -裝. 订 經濟部中央揉率局WC工消费合作社印製 其中: R表甲基成6基,且該化合物係經微粒化,而具有 小於100微米之穎粒大小· 2·如申請專利範«第1項之化粧品級合物,其中R表乙 基,且式(I)化合物係爲一種實質上爲結易竓物質之 游離鎗基形式的較高燶點多形饉· 3. 如申請專利範圍第1項之化粧品组合物,其&含基於 化桩品组合物鳟重之ο·〇5%-ιχ重量之活性成份。 4. 如申請專利範面第3項之化粧品组合物,其包含基於 化桩品组合物域重之0.1%-0.2¾重量之活性成份。 17 本紙張尺度適用中國國家梂率(CNS > A4说格(210X297公釐) r
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP92200797 | 1992-03-20 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| TW300166B true TW300166B (zh) | 1997-03-11 |
Family
ID=8210491
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| TW082102065A TW300166B (zh) | 1992-03-20 | 1993-03-20 |
Country Status (20)
| Country | Link |
|---|---|
| EP (1) | EP0630228B1 (zh) |
| JP (1) | JPH07504904A (zh) |
| KR (1) | KR100239002B1 (zh) |
| AT (1) | ATE163259T1 (zh) |
| AU (1) | AU666535B2 (zh) |
| CA (1) | CA2132098C (zh) |
| CY (1) | CY2088B1 (zh) |
| DE (1) | DE69317044T2 (zh) |
| DK (1) | DK0630228T3 (zh) |
| ES (1) | ES2113527T3 (zh) |
| FI (1) | FI106533B (zh) |
| GR (1) | GR3026422T3 (zh) |
| IL (1) | IL105110A (zh) |
| MX (1) | MX9301536A (zh) |
| NO (1) | NO304945B1 (zh) |
| NZ (1) | NZ249851A (zh) |
| SG (1) | SG48869A1 (zh) |
| TW (1) | TW300166B (zh) |
| WO (1) | WO1993018743A1 (zh) |
| ZA (1) | ZA931983B (zh) |
Families Citing this family (43)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP0872229A1 (en) | 1997-04-14 | 1998-10-21 | Janssen Pharmaceutica N.V. | Compositions containing an antifungal and a phospholipid |
| WO1998052518A1 (en) * | 1997-07-02 | 1998-11-26 | Neutrogena Corporation | Methods for using compositions containing dichlorophenyl imidazoldioxolan to treat seborrheic dermatitis, dandruff, psoriasis, and acne, and compositions thereof |
| CA2309373A1 (en) * | 1999-05-27 | 2000-11-27 | Johnson & Johnson Consumer Companies, Inc. | Novel topical formulations |
| FR2874321B1 (fr) | 2004-08-17 | 2010-11-26 | Oreal | Composition topique comprenant des particules poreuses chargees et un compose absorbant le sebum |
| FR2875134B1 (fr) | 2004-09-16 | 2007-08-24 | Oreal | Utilisation cosmetique d'une composition renfermant un derive ascorbique et des particules de polyamide |
| US7300649B2 (en) | 2005-02-11 | 2007-11-27 | Genepharm, Inc. | Cosmetic and cosmeceutical compositions for restoration of skin barrier function |
| FR2918269B1 (fr) | 2007-07-06 | 2016-11-25 | Oreal | Composition de protection solaire contenant l'association d'un polymere semi-cristallin et de particules de latex creuses. |
| FR2918561B1 (fr) | 2007-07-09 | 2009-10-09 | Oreal | Utilisation pour la coloration de la peau de l'acide dehydroascorbique ou des derives polymeres ; procedes de soin et/ou de maquillage. |
| FR2918563B1 (fr) | 2007-07-12 | 2009-12-04 | Oreal | Composition photoprotectrice fluide aqueuse a base d'un polymere polyamide a terminaison amide tertiaire. |
| FR2918883B1 (fr) | 2007-07-17 | 2010-01-15 | Oreal | Utilisation d'un extrait bacterien cultive sur une eau thermale pour le traitement des peaux seches |
| FR2931064B1 (fr) | 2008-05-14 | 2010-08-13 | Oreal | Composition cosmetique contenant un derive de dibenzoylmethane et un derive de pyrrolidinone; procede de photostabilisation du derive de dibenzoylmethane |
| FR2936706B1 (fr) | 2008-10-08 | 2010-12-17 | Oreal | Composition cosmetique contenant un derive de dibenzoylmethane et un compose dithiolane ; procede de photostabilisation du derive de dibenzoylmethane |
| FR2939036B1 (fr) | 2008-12-01 | 2010-12-17 | Oreal | Procede de coloration artificielle de la peau utilisant un melange de carotenoide et de colorant vert lidophile ; nouveau melange de colorants lipophiles ; composition |
| FR2954140A1 (fr) | 2009-12-17 | 2011-06-24 | Oreal | Compositions cosmetiques ou dermatologiques a base de bacteriocines et de prebiotiques |
| FR2956582B1 (fr) | 2010-02-19 | 2012-08-24 | Oreal | Composition sous forme de poudre comprenant au moins une charge, au moins une huile essentielle et au moins un ester hydroxyle de polyol et d'acide(s) carboxylique(s) en c4 a c16 |
| FR2968569B1 (fr) | 2010-12-13 | 2013-01-04 | Oreal | Procede de traitement de la peau grasse non acneique. |
| CN102627633A (zh) * | 2012-03-21 | 2012-08-08 | 浙江丽晶化学有限公司 | 新康唑提纯新方法 |
| JP6559958B2 (ja) | 2012-04-11 | 2019-08-14 | ロレアル | 自立性美容シート |
| FR2992182B1 (fr) | 2012-06-21 | 2014-06-20 | Oreal | Composition a effet matifiant comprenant des particules d'aerogels hydrophobes et des particules de perlite |
| FR2992200B1 (fr) | 2012-06-21 | 2014-11-28 | Oreal | Composition a effet matifiant comprenant des particules d'aerogels hydrophobes et un ether de polyol et de polyalkyleneglycols |
| FR2992210B1 (fr) | 2012-06-21 | 2014-11-28 | Oreal | Composition a effet matifiant comprenant des particules d'aerogels hydrophobes et des particules d'elastomeres de silicone |
| FR2992183B1 (fr) | 2012-06-21 | 2015-04-10 | Oreal | Composition a effet matifiant comprenant des particules d'aerogels hydrophobes et des particules de polymeres expanses |
| FR2992185B1 (fr) | 2012-06-21 | 2015-03-27 | Oreal | Composition a effet matifiant comprenant des particules d'aerogels hydrophobes et des particules de silice |
| FR2992188B1 (fr) | 2012-06-21 | 2014-11-28 | Oreal | Composition a effet matifiant comprenant des particules d'aerogels hydrophobes et un tensioactif non ionique oxyethylene |
| FR2992184B1 (fr) | 2012-06-21 | 2015-03-27 | Oreal | Composition a effet matifiant comprenant des particules d'aerogels hydrophobes et un amidon |
| FR3000670B1 (fr) | 2013-01-10 | 2015-02-27 | Oreal | Composition cosmetique apaisante a base d'acide salicylique. |
| WO2014125920A1 (en) | 2013-02-14 | 2014-08-21 | L'oreal | Multilayered sheet for absorbing sweat |
| JP2015209380A (ja) | 2014-04-24 | 2015-11-24 | ロレアル | 化粧用組成物 |
| FR3045322B1 (fr) | 2015-12-18 | 2019-12-20 | L'oreal | Procede de coloration d'une composition cosmetique de base |
| FR3112283A1 (fr) | 2020-07-07 | 2022-01-14 | L'oreal | Compositions anti-acné |
| CN115916147A (zh) | 2020-05-19 | 2023-04-04 | 欧莱雅 | 抗痤疮组合物 |
| WO2021255255A1 (en) | 2020-06-19 | 2021-12-23 | L'oreal | Composition comprising a polyol, a polyglycerol ester, a hyaluronic acid salt and a specific hydrophilic polymer |
| FR3111546B1 (fr) | 2020-06-19 | 2023-04-07 | Oreal | Composition comprenant un polyol, un ester de polyglycérol, un sel d’acide hyaluronique et un polymère hydrophile spécifique |
| FR3142901B1 (fr) | 2022-12-09 | 2025-12-05 | Oreal | Compositions cosmétiques avec meilleure résistance à l’usure et au transfert |
| WO2024049867A1 (en) | 2022-08-31 | 2024-03-07 | L'oreal | Cosmetic compositions with improved wear and transfer resistance |
| WO2024127414A1 (en) | 2022-12-15 | 2024-06-20 | L'oreal | A cosmetic composition for acne control and methods thereof |
| FR3145864B1 (fr) | 2023-02-16 | 2025-10-31 | Oreal | Composition cosmétique pour le contrôle de l’acné et procédés associés |
| WO2024163629A1 (en) | 2023-01-31 | 2024-08-08 | L'oreal | Cosmetic compositions containing glycerolated silicone resin and hydrogel-in-oil dispersion |
| FR3147500A1 (fr) | 2023-04-06 | 2024-10-11 | L'oreal | Compositions cosmétiques contenant de la résine de silicone glycérolée et une dispersion hydrogel dans l’huile |
| FR3154002B3 (fr) | 2023-10-16 | 2025-11-07 | Oreal | Compositions d’émulsion contenant un composé pullulane hydrophobiquement modifié et un filmogène en phase aqueuse |
| WO2025006850A1 (en) | 2023-06-30 | 2025-01-02 | L'oreal | W/o emulsion compositions containing a hydrophobically-modified pullulan compound and an aqueous phase film former |
| FR3154317B3 (fr) | 2023-10-18 | 2025-11-07 | Oreal | Compositions d’émulsions contenant un composé dendrimère de carbosiloxane et un filmogène en phase aqueuse |
| FR3160580A3 (fr) | 2024-04-02 | 2025-10-03 | L'oreal | Compositions incluant un polymère organosilicone et un filmogène en phase aqueuse |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4144346A (en) * | 1977-01-31 | 1979-03-13 | Janssen Pharmaceutica N.V. | Novel 1-(1,3-dioxolan-2-ylmethyl)-1H-imidazoles |
| DE3927460A1 (de) * | 1989-08-19 | 1991-02-21 | Henkel Kgaa | Entzuendungshemmende wirkstoffe fuer kosmetische praeparate |
| CA2056803A1 (en) * | 1990-12-06 | 1992-06-07 | Llyr G. Griffiths | Hair treatment composition |
-
1993
- 1993-03-12 ES ES93906537T patent/ES2113527T3/es not_active Expired - Lifetime
- 1993-03-12 JP JP5516238A patent/JPH07504904A/ja active Pending
- 1993-03-12 WO PCT/EP1993/000599 patent/WO1993018743A1/en not_active Ceased
- 1993-03-12 AT AT93906537T patent/ATE163259T1/de not_active IP Right Cessation
- 1993-03-12 NZ NZ249851A patent/NZ249851A/en not_active IP Right Cessation
- 1993-03-12 CA CA002132098A patent/CA2132098C/en not_active Expired - Lifetime
- 1993-03-12 EP EP93906537A patent/EP0630228B1/en not_active Expired - Lifetime
- 1993-03-12 DE DE69317044T patent/DE69317044T2/de not_active Expired - Lifetime
- 1993-03-12 AU AU37484/93A patent/AU666535B2/en not_active Expired
- 1993-03-12 DK DK93906537.1T patent/DK0630228T3/da active
- 1993-03-12 KR KR1019940703000A patent/KR100239002B1/ko not_active Expired - Fee Related
- 1993-03-12 SG SG1996003215A patent/SG48869A1/en unknown
- 1993-03-18 MX MX9301536A patent/MX9301536A/es unknown
- 1993-03-19 ZA ZA931983A patent/ZA931983B/xx unknown
- 1993-03-19 IL IL10511093A patent/IL105110A/xx not_active IP Right Cessation
- 1993-03-20 TW TW082102065A patent/TW300166B/zh active
-
1994
- 1994-09-19 NO NO943475A patent/NO304945B1/no not_active IP Right Cessation
- 1994-09-19 FI FI944339A patent/FI106533B/fi active
-
1998
- 1998-03-20 GR GR980400612T patent/GR3026422T3/el unknown
- 1998-06-16 CY CY9800006A patent/CY2088B1/xx unknown
Also Published As
| Publication number | Publication date |
|---|---|
| HK1006208A1 (zh) | 1999-02-12 |
| ATE163259T1 (de) | 1998-03-15 |
| IL105110A0 (en) | 1993-07-08 |
| KR100239002B1 (ko) | 2000-02-01 |
| GR3026422T3 (en) | 1998-06-30 |
| AU3748493A (en) | 1993-10-21 |
| EP0630228B1 (en) | 1998-02-18 |
| CY2088B1 (en) | 2002-04-05 |
| DE69317044T2 (de) | 1998-06-10 |
| DK0630228T3 (da) | 1998-06-02 |
| JPH07504904A (ja) | 1995-06-01 |
| DE69317044D1 (de) | 1998-03-26 |
| KR950700049A (ko) | 1995-01-16 |
| CA2132098C (en) | 2004-10-12 |
| WO1993018743A1 (en) | 1993-09-30 |
| IL105110A (en) | 2003-03-12 |
| SG48869A1 (en) | 1998-05-18 |
| CA2132098A1 (en) | 1993-09-30 |
| NO943475L (no) | 1994-11-18 |
| NZ249851A (en) | 1995-10-26 |
| FI944339L (fi) | 1994-09-19 |
| NO943475D0 (no) | 1994-09-19 |
| AU666535B2 (en) | 1996-02-15 |
| MX9301536A (es) | 1994-01-31 |
| FI944339A0 (fi) | 1994-09-19 |
| ES2113527T3 (es) | 1998-05-01 |
| NO304945B1 (no) | 1999-03-08 |
| EP0630228A1 (en) | 1994-12-28 |
| FI106533B (fi) | 2001-02-28 |
| ZA931983B (en) | 1994-09-19 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| TW300166B (zh) | ||
| CN104337705B (zh) | 含有葡糖酸内酯和乳糖酸的化妆品组合物 | |
| US5641494A (en) | Agent for regulating the greasiness of the skin | |
| JPS6127094B2 (zh) | ||
| JP2004189732A (ja) | 藍草から得られた抗菌活性物質及びこれを含有する各種組成物 | |
| EP0632717B1 (en) | Agent for use as an anti-irritant | |
| TWI668014B (zh) | 組成物、化妝料以及神經醯胺類的結晶化·析出抑制方法 | |
| WO2022181744A1 (ja) | リポソーム組成物 | |
| US6022532A (en) | Agent for regulating the greasiness of the skin | |
| HK1256597A1 (zh) | 含有细胞老化抑制剂作为有效成分的皮肤皱纹改善用及皮肤损伤炎症疾病治疗用组合物 | |
| JPH07242542A (ja) | 化粧料 | |
| JP2000063256A (ja) | 皮膚外用剤 | |
| JP2001335478A (ja) | 皮膚外用剤 | |
| JP5247348B2 (ja) | 皮膚外用剤 | |
| HK1006208B (zh) | 供调节皮肤油脂性之制剂 | |
| HK1227754B (zh) | 组合物、化妆料 | |
| HK1010343B (zh) | 一种抗刺激剂 | |
| JPH05117295A (ja) | 香粧品素材及び外用医薬基剤 | |
| JP2006232769A (ja) | セラミド合成促進剤 | |
| JPH04117316A (ja) | 化粧料 | |
| HK1227754A1 (zh) | 组合物、化妆料 | |
| JPH08231371A (ja) | 化粧料 | |
| JPH06312912A (ja) | 化粧料 |